RxDoctor Payments Data

Thomas Todoran, MD

Interventional Cardiology · Pawleys Island, SCNPI 1104945955

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.1%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 69.7% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $46,044, more than ten times the $395 reported in 2019. Among interventional cardiology clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$94,646in general payments, 2019–2025

Across 188 payments — averaging $503.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$66K
  • Recor Medical Inc$15K
  • Neptune Medical Inc.$6K
  • Angiodynamics, Inc.$6K
  • GE HealthCare$700
  • Boston Scientific$159
  • plus $612 from 13 others
$234,248in research payments, 2019–2025

Across 79 payments — averaging $2965.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Recor Medical Inc$127K
  • Inari Medical, Inc.$59K
  • Medtronic$27K
  • Abbott$22K

What the payments were for

  • Consulting fees$55,97859%
  • Speaking & faculty fees$19,08120%
  • Travel & lodging$12,22013%
  • Food & beverage$7,3668%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$94,646 in reported general payments places this provider in the 90th percentile of 117 interventional cardiology providers in South Carolina.

See all interventional cardiology providers in South Carolina

Medicare billing

Part B allowed, 2024
$95,253
Medicare patients
1,812
Services billed
2,377

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban52$49,988
EntrestoSacubitril/Valsartan12$8,101
Ranolazine ErRanolazine27$2,557
Metoprolol Succinate114$1,658
Atorvastatin Calcium175$1,651
Ezetimibe35$1,335
Rosuvastatin Calcium54$639
Amlodipine Besylate77$387
Cilostazol19$375
Furosemide61$374
Isosorbide Mononitrate ErIsosorbide Mononitrate52$361
Carvedilol47$357
Valsartan14$352
Metoprolol Tartrate55$349
ClopidogrelClopidogrel Bisulfate32$337

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Pawleys Island

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →